New Medtronic Multi-Electrode Renal Denervation Device Gets CE Mark and Australian Approval

Medtronic (NYSE: MDT) has announced that its multi-electrode Symplicity Spyral™ catheter and Symplicity G3™ radio frequency (RF) generator for patients with treatment-resistant hypertension has received both the CE Mark (Conformité Européenne) in Europe and Therapeutic Goods Administration (TGA) listing in Australia.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news